Showing 21 - 40 results of 9,506 for search 'Plus three', query time: 0.17s Refine Results
  1. 21

    RESPONSE OF VEGETATIVE GROWTH OF TWO CVS. FIG SEEDLINGS TO TREATMENT WITH HUMIC ACID , LIQUID ESSENTIAL PLUS AND GA3 by Ayad Al-Alaf

    Published 2019-06-01
    “…(Aswad Dyalla and White Adriatic) , planted polyethylene plastic  in the lath house were fertilized at three levels with humic acid (0 , 1 and 2 ml.L<sup>-1</sup>) liquid fertilizer (1-0-1) Essential plus (0 , 1 and 2 ml.L<sup>-1</sup>)and GA<sub>3</sub> (0, 25 and 50 mg.L<sup>-1</sup>) to improve vegetative growth of the seedlings. …”
    Get full text
    Article
  2. 22

    Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis by Jie Dai, Tianxiao Xu, Lifeng Li, Meiyu Fang, Jing Lin, Jun Cao, Xue Bai, Caili Li, Xiaoting Wei, Junjie Gu, Yaoyao Liu, Xuan Gao, Xuefeng Xia, Jun Guo, Yu Chen, Lili Mao, Lu Si

    Published 2025-01-01
    “…Methods Forty‐three intention‐to‐treat (ITT) patients received intravenous administration of atezolizumab and bevacizumab every 3 weeks. …”
    Get full text
    Article
  3. 23
  4. 24
  5. 25
  6. 26

    A non-inferiority, phase III trial of gemcitabine plus capecitabine gemcitabine plus carboplatin as first-line therapy and tumor-infiltrating lymphocytes as a prognostic biomarker in patients with advanced triple-negative breast cancer by Xiaodong Liu, Weipeng Zhao, Yongsheng Jia, Yehui Shi, Xu Wang, Shufen Li, Pin Zhang, Chen Wang, Chunfang Hao, Zhongsheng Tong

    Published 2024-12-01
    “…Background: Gemcitabine plus capecitabine (GX) shows survival benefit and manageable safety in patients with advanced triple-negative breast cancer (TNBC) but there is a paucity of phase III trial evidence. …”
    Get full text
    Article
  7. 27

    [Comment] Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older pa tients with RAS wild-type metastatic colorectal cancer:an analysis of the randomised trial FIRE-3 by Wu Deqing

    Published 2022-08-01
    “…This retrospective analysis of phase III FIRE-3 trial assesses the efficacy of FOLFIRI plus either cetuximab or bevacizumab according to the patients' age and sidedness of primary tumour. …”
    Get full text
    Article
  8. 28
  9. 29
  10. 30

    Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer by Julien Taieb, Marwan Fakih, Gabor Liposits, Gerald W. Prager, Eric Van Cutsem, Fortunato Ciardiello, Nadia Amellal, Elizabeth Calleja, Mei Liu, Lucas Roby, Josep Tabernero, Thierry André

    Published 2025-01-01
    “…BackgroundTrifluridine/tipiracil (FTD/TPI) is approved as monotherapy and in combination with bevacizumab for the treatment of patients with refractory metastatic colorectal cancer (mCRC). FTD/TPI plus bevacizumab showed good tolerability in the phase 3 SOLSTICE (first-line) and SUNLIGHT (later-line) trials. …”
    Get full text
    Article
  11. 31

    Cost-effectiveness Analysis of Ribociclib plus Letrozole versus Palbociclib plus Letrozole in the United Kingdom by Gaurav Suri, David Chandiwana, Adam Lee, Rohit Mistry

    Published 2019-04-01
    “…# Objective To evaluate the cost-effectiveness of ribociclib plus letrozole versus palbociclib plus letrozole in post-menopausal women with hormone receptor positive (HR+) and human epidermal growth receptor 2 negative (HER2-) advanced breast cancer from a UK payer perspective…”
    Get full text
    Article
  12. 32

    Cytotoxicity and genotoxicity evaluation of AH Plus, Well-Root ST, and AH Plus Bioceramic Sealer by Aysenur Oncu, Duru Aras Tosun, Berkan Celikten, Arda Buyuksungur

    Published 2025-05-01
    “…Abstract Background This study aimed to evaluate the cytotoxicity and genotoxicity of AH Plus, Well-Root ST, and AH Plus Bioceramic Sealer on osteoblast cells. …”
    Get full text
    Article
  13. 33
  14. 34
  15. 35

    Three-Year Outcomes of Cross-Linking PLUS (Combined Cross-Linking with Femtosecond Laser Intracorneal Ring Segments Implantation) for Management of Keratoconus by Mohammed Iqbal Hafez Saleem, Hosam A. Ibrahim Elzembely, Mortada Ahmed AboZaid, Mohammed Elagouz, Ahmed Mohamed Saeed, Osama Ali Mohammed, Ahmed Gad Kamel

    Published 2018-01-01
    “…To analyze the results of three-year outcomes of combined epithelium-on cross-linking with femtosecond laser ICRS (cross-linking PLUS) for keratoconus management. …”
    Get full text
    Article
  16. 36

    Efficacy of Revolution® Plus (selamectin plus sarolaner) against Amblyomma americanum (lone star ticks) in cats by Susan Holzmer, Adriano F. Vatta, Sara Chapin, Vickie King, Jamie A. E. Myers

    Published 2025-08-01
    “…Abstract Background The efficacy of a topical combination product, Revolution® Plus, containing selamectin and sarolaner was evaluated for efficacy against Amblyomma americanum ticks in cats. …”
    Get full text
    Article
  17. 37

    Experimental hut evaluation of DawaPlus 3.0 LN and DawaPlus 4.0 LN treated with deltamethrin and PBO against free-flying populations of Anopheles gambiae s.l. in Vallée du Kou, Burkina Faso. by Koama Bayili, Sévérin N'Do, Rajpal S Yadav, Moussa Namountougou, Abdoulaye Ouattara, Roch K Dabiré, Georges A Ouédraogo, Abdoulaye Diabaté

    Published 2019-01-01
    “…<h4>Principal findings</h4>Significantly higher rates of mortality and blood-feeding inhibition were observed with unwashed DawaPlus 4.0 (36%; 47.5%) than unwashed DawaPlus 3.0 (11.8%; 33.3%), DawaPlus 2.0 (4.3%; 6.4%) or untreated net (P < 0.05). …”
    Get full text
    Article
  18. 38
  19. 39
  20. 40